Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can money help cure cancer stress? new program targets financial toxicity

NCT ID NCT04931251

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a financial navigation program for cancer patients in rural and non-rural North Carolina. The program helped patients find financial assistance to reduce the burden of cancer costs. Researchers measured changes in financial toxicity and quality of life in 258 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Financial navigation program
What this could lead to
If successful, this program could provide a model for helping cancer patients manage the financial burden of treatment, reducing stress and improving well-being.
What could go wrong
This is a completed study, but results may not apply to all regions or cancer types. The program's effectiveness depends on available resources and patient engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

258 people

The number who actually took part.

Started

Nov 2021

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients 18 years of age and older * Patients with any type of cancer diagnosed within 5 years and/or living with advanced disease * Patients who score 22 or lower on the COST measure indicating high FT * Patients must be able to read and speak English Exclusion Criteria: * Participants without a cancer diagnosis * Patients diagnosed more than 5 years ago without advanced disease * Patients or caregivers under the age of 18 * Patients who do not sign the consent form * Patients who do not complete the baseline COST survey * Patients who cannot read and speak English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carteret Health Care Cancer Center

    Morehead City, North Carolina, 28557, United States

  • NC Basnight Cancer Hospital

    Chapel Hill, North Carolina, 27514, United States

  • Novant Health

    Charlotte, North Carolina, 28207, United States

  • Pardee UNC Health Care, Pardee Cancer Center

    Hendersonville, North Carolina, 28739, United States

  • The Outer Banks Hospital

    Nags Head, North Carolina, 27959, United States

  • UNC Lenoir Cancer Care Services

    Kinston, North Carolina, 28501, United States

  • Vidant Medical Center, Cancer Center

    Greenville, North Carolina, 27834, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.